Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_07-cv-00586/USCOURTS-caed-2_07-cv-00586-2/pdf.json

Parties Involved:
Aventis Pharmaceuticals Corporation
Defendant
Centocor Research and Development, Inc.
Defendant
Nelvin McDermott
Plaintiff

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

1

UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF CALIFORNIA

NELVIN MCDERMOTT, personally

and as Guardian Ad Litem for

Anna Marie Irena and

Christopher McDermott,

NO. CIV. S-07-586 LKK/DAD 

Plaintiffs,

v.

O R D E R

CENTOCOR RESEARCH AND 

DEVELOPMENT, INC., a

Pennsylvania Corporation,

AVENTIS PHARMACEUTICALS

CORPORATION, a Delaware

Corporation, DOES 2 through

10 and ROE Corporation 1

through 10,

Defendants.

 /

As stated during the hearing on plaintiffs’ motion for

approval of minor compromise on May 20, 2008, the court grants the

motion except that it approves attorney’s fees in the amount of 25

percent rather than 40 percent. Accordingly, plaintiffs’ counsel

is entitled to $6,875 in fees plus $1,074.20 in costs. 

////

Case 2:07-cv-00586-LKK -DAD Document 34 Filed 05/21/08 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

2

IT IS SO ORDERED.

DATED: May 21, 2008.

Case 2:07-cv-00586-LKK -DAD Document 34 Filed 05/21/08 Page 2 of 2